新华制药：恩他卡朋片取得注册证

Group 1 - The core point of the article is that Xinhua Pharmaceutical has received approval from the National Medical Products Administration for the registration certificate of Entacapone tablets, indicating a significant development for the company [1] Group 2 - Xinhua Pharmaceutical's stock closed at 15.15 yuan on March 4 [1] - The product name approved is "Entacapone tablets," which suggests potential new revenue streams for the company [1]